Literature DB >> 9506544

Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado-Joseph disease.

O Onodera1, J Idezuka, S Igarashi, Y Takiyama, K Endo, H Takano, M Oyake, H Tanaka, T Inuzuka, T Hayashi, T Yuasa, J Ito, T Miyatake, S Tsuji.   

Abstract

Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disease characterized by cerebellar ataxia associated to varying degrees with pyramidal signs, extrapyramidal signs, or peripheral amyotrophy. It is caused by unstable expansion of the CAG repeat in the MJD1 gene on chromosome 14q32.1. To determine how the neurodegenerative process in the central nervous system of patients with MJD correlates with the size of expanded CAG repeats in the MJD1 gene and other factors, we performed detailed quantitative analyses of findings of magnetic resonance imaging of the central nervous system of 21 patients with MJD of various ages and with various sizes of expanded CAG repeats. We found that atrophy of the brainstem and cerebellar vermis in MJD patients is closely correlated not only with the size of expanded CAG repeat in the MJD1 gene but also with patient age, which suggests that the neurodegenerative process in MJD is regulated by the size of expanded CAG repeats as well as by the patient age.

Entities:  

Mesh:

Year:  1998        PMID: 9506544     DOI: 10.1002/ana.410430305

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  15 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  Magnetic resonance imaging in spinocerebellar ataxias.

Authors:  Susanne Döhlinger; Till-Karsten Hauser; Johannes Borkert; Andreas R Luft; Jörg B Schulz
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 3.  Machado-Joseph disease/spinocerebellar ataxia type 3.

Authors:  Henry Paulson
Journal:  Handb Clin Neurol       Date:  2012

4.  CAG repeats determine brain atrophy in spinocerebellar ataxia 17: a VBM study.

Authors:  Kathrin Reetz; Alexandra Kleiman; Christine Klein; Rebekka Lencer; Christine Zuehlke; Kathrin Brockmann; Arndt Rolfs; Ferdinand Binkofski
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

5.  Hot cross bun sign in a late-onset SCA1 patient.

Authors:  Ying Wang; Kishin Koh; Ryusuke Takaki; Kazumasa Shindo; Yoshihisa Takiyama
Journal:  Neurol Sci       Date:  2016-06-13       Impact factor: 3.307

6.  Prospective motion correction of high-resolution magnetic resonance imaging data in children.

Authors:  Timothy T Brown; Joshua M Kuperman; Matthew Erhart; Nathan S White; J Cooper Roddey; Ajit Shankaranarayanan; Eric T Han; Dan Rettmann; Anders M Dale
Journal:  Neuroimage       Date:  2010-06-11       Impact factor: 6.556

7.  Striatal dopamine function in a family with multiple SCA-3 phenotypes.

Authors:  Esther Cubo; Mateo Diez López; Jon Infante Ceberio; Isabel Lanchas Alfonso; Begoña Miguel Martinez; José Berciano; Fernando Iglesias; José A Obeso
Journal:  J Neurol       Date:  2010-08-31       Impact factor: 4.849

8.  Corticospinal tract involvement in spinocerebellar ataxia type 3: a diffusion tensor imaging study.

Authors:  Bruno Shigueo Yonekura Inada; Thiago Junqueira Ribeiro Rezende; Fernando Vieira Pereira; Lucas Ávila Lessa Garcia; Antônio José da Rocha; Pedro Braga Neto; Orlando Graziani Povoas Barsottini; Marcondes Cavalcante França; José Luiz Pedroso
Journal:  Neuroradiology       Date:  2020-09-02       Impact factor: 2.804

Review 9.  Caring for Machado-Joseph disease: current understanding and how to help patients.

Authors:  Anelyssa D'Abreu; Marcondes C França; Henry L Paulson; Iscia Lopes-Cendes
Journal:  Parkinsonism Relat Disord       Date:  2009-10-06       Impact factor: 4.891

10.  Spinocerebellar ataxia: patient and health professional perspectives on whether and how patents affect access to clinical genetic testing.

Authors:  Ashton Powell; Subhashini Chandrasekharan; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.